Guangdong Taienkang Pharmaceutical Co., Ltd. (SHE:301263)

China flag China · Delayed Price · Currency is CNY
19.89
+0.06 (0.30%)
At close: Jul 29, 2026
Market Cap10.11B -36.8%
Revenue (ttm)679.75M -5.1%
Net Income25.67M -72.8%
EPS0.05 -70.9%
Shares Out 508.21M
PE Ratio393.79
Forward PEn/a
Dividend0.04 (0.21%)
Ex-Dividend DateJun 1, 2026
Volume3,919,060
Open19.83
Previous Close19.83
Day's Range19.54 - 20.14
52-Week Range17.52 - 34.15
Beta0.30
Analystsn/a
Price Targetn/a
Earnings DateAug 18, 2026

About SHE:301263

Guangdong Taienkang Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China and internationally. The company offers various products covering various therapeutic areas, including sexual health medicines, ophthalmic medicines, gastrointestinal medicines, Chinese patent medicines and external medicines, and sanitary materials in the form of tablets, pills, injections, and essential oils; medical technology and technology transfer services; and medical devices. It also operates as ... [Read more]

Sector Healthcare
Founded 1999
Employees 1,154
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301263
Full Company Profile

Financial Performance

In 2025, SHE:301263's revenue was 674.90 million, a decrease of -6.40% compared to the previous year's 721.03 million. Earnings were 28.63 million, a decrease of -73.54%.

Financial Statements